Escuela de Medicina, Universidad San Francisco de Quito USFQ, Quito, Pichincha, 170901, Ecuador.
Health Research Group, Universidad San Francisco de Quito USFQ, Quito, Pichincha, 170901, Ecuador.
F1000Res. 2020 Jun 26;9:651. doi: 10.12688/f1000research.23737.1. eCollection 2020.
Acne-induced scarring is associated with a similar burden as acne, i.e. diminished quality of life, and may be avoided if patients receive appropriate and timely acne treatment. In 2017, a four item-Acne-Scar Risk Assessment Tool (4-ASRAT) was designed by Tan . to categorise patients with acne into lower-risk or higher-risk for acne scarring. Its applicability outside the initial study population (France, Brazil and United States) remains to be determined. A study protocol was developed to create a systematic approach for validating and adapting 4-ASRAT to different populations, Ecuador in this case. The protocol was reviewed by 11 local and international dermatologists and pilot-tested in an Ecuadorian population using a sample of 10 participants who currently had or had had acne. Feedback from the pilot study was used to improve the study protocol. The results of the pilot study are included here, and the final study protocol is available as extended data. The protocol proved to be applicable. Images taken of participants were a valuable resource for dermatological evaluation about the presence or absence of acne scars. Tangential light is necessary for this evaluation. Although dermatological assessments varied, we concluded that assessment by three local dermatologists for each participant was adequate for reaching a consensus on the presence or absence of acne scars. Considering the morbidity related to acne and acne scars, tools designed as prevention that alert patients about risk of developing scarring are necessary. The proposed protocol shows a feasible way of validating and adapting 4-ASRAT to different populations.
痤疮引起的瘢痕与痤疮有相似的负担,即生活质量下降,如果患者接受适当和及时的痤疮治疗,可能避免出现瘢痕。2017 年,Tan 设计了一个四项痤疮瘢痕风险评估工具(4-ASRAT),以将痤疮患者分为低风险或高风险痤疮瘢痕。其在初始研究人群(法国、巴西和美国)之外的适用性仍有待确定。该研究制定了一项方案,以创建一种系统的方法来验证和适应 4-ASRAT 到不同的人群,在这种情况下是厄瓜多尔。该方案由 11 名当地和国际皮肤科医生进行了审查,并在厄瓜多尔人群中进行了试点测试,使用了 10 名目前患有或曾经患有痤疮的参与者的样本。试点研究的反馈用于改进研究方案。本研究包括试点研究的结果,最终研究方案作为扩展数据提供。该方案被证明是适用的。对参与者拍摄的图像是进行皮肤科评估有无痤疮瘢痕的有价值资源。评估需要切线光。尽管皮肤科评估存在差异,但我们得出结论,对每个参与者进行三位当地皮肤科医生的评估足以就痤疮瘢痕的存在与否达成共识。考虑到与痤疮和痤疮瘢痕相关的发病率,设计用于预防的工具,提醒患者有发生瘢痕的风险是必要的。所提出的方案显示了一种可行的方法,可以验证和适应 4-ASRAT 到不同的人群。